(Nasdaq: BMRA) (“Biomerica” or the “Company”), a global biomedical technology company focused on innovative diagnostic-guided therapies, today announced the commercial launch of its inFoods® platform ...
Company and Laboratory Partner Believe Properly Documented Claims Are Positioned for Payment Under Existing $300 CMS Reimbursement Rate The Medicare Administrative Contractor (MAC) responsible for ...
Biomerica Inc. has appointed Scott Madel as Chief Commercial Officer, bringing over 20 years of experience in revenue growth and commercialization in the healthcare and diagnostics sectors. Madel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results